E Kuntz

573 total citations
37 papers, 336 citations indexed

About

E Kuntz is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, E Kuntz has authored 37 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in E Kuntz's work include Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (6 papers) and Infectious Diseases and Tuberculosis (5 papers). E Kuntz is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (6 papers) and Infectious Diseases and Tuberculosis (5 papers). E Kuntz collaborates with scholars based in Germany, United States and Poland. E Kuntz's co-authors include Marek Droździk, Karl‐Josef Gundermann, Elsie R. Shore, Marcia L. McCoy, H Liehr, Lisa‐Katrin Kaufmann and E. Schneider and has published in prestigious journals such as Journal of Molecular Medicine, Pharmacological Reports and Lung.

In The Last Decade

E Kuntz

26 papers receiving 287 citations

Peers

E Kuntz
Comparison fields: 5 of 98
  • Epidemiology 132
  • Hepatology 73
  • Molecular Biology 61
  • Surgery 56
  • Endocrinology, Diabetes and Metabolism 37
Replace R Katz with:
R Katz Chile
Y Yajima Japan
Kui Chun Lam Hong Kong
R. M. Haslam United Kingdom
K. R. Hill United Kingdom
Yasmin Singh India
Keisai Hiroishi Japan
Takuji Fujisawa Japan
Mohamed Egypt
Ling Mei China
R Katz Chile View profile →
Citations per field, relative to E Kuntz
E Kuntz · 1×
Citations per year, relative to E Kuntz
E Kuntz · 1×

Countries citing papers authored by E Kuntz

Since Specialization
Citations

This map shows the geographic impact of E Kuntz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Kuntz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Kuntz more than expected).

Fields of papers citing papers by E Kuntz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Kuntz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Kuntz. The network helps show where E Kuntz may publish in the future.

Co-authorship network of co-authors of E Kuntz

This figure shows the co-authorship network connecting the top 25 collaborators of E Kuntz. A scholar is included among the top collaborators of E Kuntz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Kuntz. E Kuntz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 79
2 4
3
Silymarin : in the treatment of liver diseases
6
4
[The treatment of tuberculosis with PAS-streptomycin pantothenate in venous perfusion].
0
5
["Essential" phospholipids in hepatology (experimental and clinical tests)].
1
6
Radiation treatment plans inadequate for disasters.
1
7
Hospitals prepare radiation plans in wake of nuclear plant accident.
4
8
[Clinical aspects of chronic bronchitis (author's transl)].
0
9
Die Pleuraergüsse : Differentialdiagnose, Klinik und Therapie
1
10
Toxic liver damage due to ethionamide.
1
11 4
12 4
13 0
14
[Acute peroral trichloroethylene poisoning].
2
15 0
16
[Treatment of allergic-hyperergic and toxic forms of tuberculosis with tuberculostatics and prednisolone].
1
17
[Combination treatment of tuberculosis with PAS-INH-streptomycin infusions].
3
18 4
19 5
20
[Cholinergic crisis in the treatment of myasthenia gravis].
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026